The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Bortezomib induction prior to autologous hematopoietic cell transplantation (AHCT) for newly diagnosed light chain amyloidosis (AL): A study of 426 patients.
 
Robert F. Cornell
Honoraria - Karyopharm Therapeutics; Takeda
Consulting or Advisory Role - Karyopharm Therapeutics; Takeda
Research Funding - Takeda
 
Parameswaran Hari
Honoraria - Amgen; Celgene; Juno Therapeutics; Novartis; Sanofi
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Karyopharm Therapeutics; Kite, a Gilead company; Pharmacyclics; Sanofi; Takeda
Research Funding - Celgene (Inst); Millennium (Inst); Onyx (Inst); Spectrum Pharmaceuticals (Inst)
 
Stacey Goodman
No Relationships to Disclose
 
Luciano J. Costa
Honoraria - Amgen; Celgene; Janssen
Consulting or Advisory Role - Abbvie; Amgen; Celgene; Karyopharm Therapeutics
Speakers' Bureau - Amgen; Sanofi
Research Funding - Amgen; Janssen
 
Raphael Fraser
No Relationships to Disclose
 
Noel Estrada-Merly
No Relationships to Disclose
 
Shaji Kumar
Consulting or Advisory Role - Abbvie (Inst); Abbvie (Inst); Adaptive Biotechnologies; Amgen (Inst); Bluebird Bio (Inst); Celgene (Inst); Genecentrix; Genentech/Roche (Inst); Janssen Oncology (Inst); Kite, a Gilead company (Inst); Merck (Inst); Molecular Partners (Inst); Oncopeptides; Takeda (Inst)
Research Funding - Abbvie (Inst); CARsgen Therapeutics (Inst); Celgene (Inst); Janssen Oncology (Inst); Kite, a Gilead company (Inst); MedImmune (Inst); Merck (Inst); Novartis (Inst); Roche/Genentech (Inst); Sanofi (Inst); Takeda (Inst); TeneoBio (Inst)
 
Muzaffar H. Qazilbash
No Relationships to Disclose
 
Anita D'Souza
Consulting or Advisory Role - Pfizer; Prothena
Research Funding - Merck (Inst); Mundipharma (Inst); Prothena (Inst); Sanofi (Inst)